Michael Schmitt

Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, 69120, Germany

Michael Schmitt, MD, PhD is currently Siebeneicher-Endowment Professor of Cellular Immu-notherapy and Head of the Good Manufacturing Practice (GMP) Facility at the University Clinic Heidelberg, Germany. He obtained his MD from the University of the Saarland, Hom-burg, Germany. At the Universities of Nagasaki and Mie, Japan he was introduced to the field of Tumor Immunology by Prof. H. Shiku. At the University of Ulm, Germany, Dr. Schmitt was trained by Prof. H. Döhner in Internal Medicine and Hematology/Oncology as well as in Stem Cell Transplantation by Prof. D. Bunjes. At the University of Rostock he served as Director of the Stem Cell Transplantation Program before he was appointed to his current position in Heidelberg. His main focus is on antigen-specific adoptive T cell transfer, cancer vaccines, mesenchymal stroma cells (MSCs), and stem cell mobilization. Dr. Schmitt obtained the No-vartis Research Prize in 1999, the Felix Skubiszewski Medal of the Medical University of Lub-lin in 2005 as well as the Hans-Jochen Illiger Memorial Prize in 2008.

Biography Updated on 28 May 2013

Scholarly Contributions [Data Provided by scopus]